Fennec Pharmaceuticals (FENC) Other financing activities (2014 - 2025)
Fennec Pharmaceuticals (FENC) posted Other financing activities of $205000.0 for Q4 2025, down 88.6% on a QoQ basis from $1.8 million in Q3 2025, and up 146.7% year-over-year from $83097.9 in Q4 2024.
Fennec Pharmaceuticals (FENC) Other financing activities (2014 - 2025) Analysis & Trends
Fennec Pharmaceuticals' Other financing activities history runs 10 years deep, the most recent figure standing at $205000.0 for Q4 2025.
- Quarterly Other financing activities rose 146.7% year-over-year to $205000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.2 million (up 68.33% YoY) and the FY2025 annual result came in at $2.2 million, up 68.33% from the prior year.
- Other financing activities was $205000.0 for Q4 2025 at Fennec Pharmaceuticals, down from $1.8 million in the prior quarter.
- Across five years, Other financing activities topped out at $1.8 million in Q3 2025 and bottomed at -$439000.0 in Q4 2024.
- A 5-year average of $340875.0 and a median of $209000.0 in 2023 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2022 — Other financing activities plunged 222.22% — and 2023, when it surged 6890.91%.
- Fennec Pharmaceuticals' Other financing activities stood at $9000.0 in 2021, then plunged by 222.22% to -$11000.0 in 2022, then jumped by 6890.91% to $747000.0 in 2023, then sank by 158.77% to -$439000.0 in 2024, then surged by 146.7% to $205000.0 in 2025.
- Business Quant data shows FENC's Other financing activities at $205000.0 in Q4 2025, $1.8 million in Q3 2025, and -$185000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Fennec Pharmaceuticals | 346.75 Mn | 309.97 Mn | 12.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 205,000.00 |
| Dec 31, 2025 | 205,000.00 |
| Sep 30, 2025 | 1.80 Mn |
| Sep 30, 2025 | 1.80 Mn |
| Jun 30, 2025 | -185,000.00 |
| Jun 30, 2025 | -185,000.00 |
| Mar 31, 2025 | 371,000.00 |
| Mar 31, 2025 | 371,000.00 |
| Dec 31, 2024 | -439,000.00 |
| Dec 31, 2024 | -439,000.00 |
| Jun 30, 2024 | 1.11 Mn |
| Jun 30, 2024 | 1.11 Mn |
| Mar 31, 2024 | 627,000.00 |
| Mar 31, 2024 | 627,000.00 |
| Dec 31, 2023 | 747,000.00 |
| Dec 31, 2023 | 747,000.00 |
| Sep 30, 2023 | 215,000.00 |
| Sep 30, 2023 | 215,000.00 |
| Jun 30, 2023 | 541,000.00 |
| Jun 30, 2023 | 541,000.00 |